Introduction: Mucopolysaccharidosis type II (MPS type II, Hunter syndrome) is a rare (~ 1/1500.000), X-linked inherited disorder (affects boys) due to deficiency of the lysosomal enzyme iduronate sulfatase (Xq.28). The complex clinical picture includes osteoarthropathy with a tendency to flexion stiffness and disability. In our country, the specific diagnosis and enzyme replacement therapy (ERT), are recently available in the Center for Genetic Pathology Cluj.
Objectives: Assessment of clinical features, radiological and imaging of osteoarthropathy in MPS type II and their evolution under ERT.
Material And Methods: The study included 9 male patients with a suggestive clinical picture of MPS type II; the diagnosis was confirmed by enzymatic assay and the patients were treated with ERT. Osteoarthropathy was assessed before treatment: a) clinical tests (joint goniometry, walking test) and b) radiology (X-rays of the hand and wrist, spine and pelvis), bone densitometry in five patients. Clinical tests were repeated after therapy.
Results: Chronic osteoarthropathy was present in all patients. Joint mobility was reduced with quasi stationary trend after 12 months of treatment. The walking test was improved after treatment. Radiological assessment revealed: hand bones changes, delayed bone age, vertebral changes, pelvis changes, kipho-scoliosis and aseptic necrosis of the femoral head in 100%, 88%, 88%, 55% and 11% respectively. Bone mineral density was normal in five of the nine patients evaluated.
Conclusions: Chronic osteoarthropathy with flexion stiffness is an essential component of the clinical picture of MPS type II. ERT allows an improvement/arrest of evolution (depending on disease severity and time of initiating therapy).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462490 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Comparative response of casein protein hydrolysate fed young and older human serum on muscle protein metabolism and myotube size.
Am J Physiol Cell Physiol
January 2025
Food for Health Ireland, University of Limerick, Ireland.
In this study we used an ex model to assess the effect of feeding older (50 - 70 y) adults a casein protein hydrolysate (CPH) compared with non-bioactive non-essential amino acid (NEAA) supplement on muscle protein synthesis (MPS) and markers of muscle protein breakdown (MPB). As a secondary objective, to assess any attenuation with aging, we compared the anabolic response to CPH-fed serum from older and young adults. Serum from seven healthy older and seven young men following overnight fast and 60 min postprandial ingestion of CPH or NEAA (0.
View Article and Find Full Text PDFEpidemiology of Mucopolysaccharidosis Type II According to the Register of the Russian Federation.
Turk Arch Pediatr
January 2025
Federal State Budgetary Scientific Institution, Research Center for Medical Genetics, Moscow, Russia.
Objective: The study aimed to evaluate the epidemiological, clinical, and molecular data of mucopolysaccharidosis type II (MPS II) patients and their outcomes using the national registry of patients in the Russian Federation (RF). Materials and Methods: In the retrospective cohort study, the authors included data from the Russian national registry of MPS II. Results: The prevalence of MPS II in RF is 0.
View Article and Find Full Text PDFInvestigation of microplastic pollution index in the urban surface water: A case study in west Godavari district, Andhra Pradesh, India.
J Environ Manage
January 2025
Departmemt of Civil Engineering, National Institute of Technology Andhra Pradesh, India. Electronic address:
Microplastics (MPs) are a growing environmental issue because of their widespread prevalence and their long-term effects on ecosystems and human health. Global studies have identified MPs in various aquatic environments, such as lake, rivers, estuaries, wastewater, and oceans. Although most MPs originate from urban surface water sources, the specific intensity, characteristics, and associated risk assessments remain unclear.
View Article and Find Full Text PDFMulti-omics analyses of early-onset familial Alzheimer's disease and Sanfilippo syndrome zebrafish models reveal commonalities in disease mechanisms.
Biochim Biophys Acta Mol Basis Dis
January 2025
Alzheimer's Disease Genetics Laboratory, School of Molecular and Biomedical Sciences, Faculty of Sciences, Engineering and Technology, The University of Adelaide, North Terrace Campus, Adelaide, SA 5005, Australia.
Sanfilippo syndrome (mucopolysaccharidosis type III, MPSIII) causes childhood dementia, while Alzheimer's disease is the most common type of adult-onset dementia. There is no cure for either of these diseases, and therapeutic options are extremely limited. Increasing evidence suggests commonalities in the pathogenesis of these diseases.
View Article and Find Full Text PDFReduced graphene oxide membrane with small nanosheets for efficient and ultrafast removal of both microplastics and small molecules.
J Hazard Mater
January 2025
Shanghai Applied Radiation Institute, State Key Lab. Advanced Special Steel, Shanghai University, Shanghai 200444, China; Key Laboratory of Comprehensive and Highly Efficient Utilization of Salt Lake Resources, Qinghai Provincial Key Laboratory of Resources and Chemistry of Salt Lakes, Qinghai Institute of Salt Lakes, Chinese Academy of Sciences, Xining, Qinghai 810008, China. Electronic address:
The clogging of sieving pores due to the complex sewage system of mixed molecules and nanoparticles of different scales is a difficulty in the membrane-based separation process. When the holes are reduced to the point where they can repel small molecules in the contaminants, large-molecule contaminants can adsorb to the holes and decrease the permeability. A similar question remains in new promising graphene oxide (GO) membranes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!